MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Long-Term Effects of Telerehabilitation on Functional Mobility and Quality of Life in Parkinson’s Disease: A Systematic Review

A. Elsayed, D. W. Ismail, H. Elshazly, Y. M.HUSSEINY, S. Elrobeigi, Y. Hamdi, M. M. Elsayed (Mansoura, Egypt)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: To evaluate the long-term effects of telerehabilitation on functional mobility and quality of life (QoL) in individuals with Parkinson’s disease (PD) and determine its sustainability as a therapeutic approach.

Background: PD is a progressive neurodegenerative disorder characterized by motor impairments and reduced QoL. Telerehabilitation, leveraging remote digital interventions, has emerged as an accessible alternative to conventional rehabilitation. However, its long-term impact on mobility and QoL remains unclear, necessitating a systematic review to assess its effectiveness.

Method: A systematic search was conducted across Cochrane, PubMed, Scopus, and Web of Science databases. Inclusion criteria encompassed randomized controlled trials (RCTs) and longitudinal studies evaluating telerehabilitation programs lasting ≥12 weeks in PD patients. Outcome measures included mobility assessments (Timed Up and Go Test, gait speed), motor function (UPDRS-III), and QoL indices (PDQ-39). Risk of bias was assessed using the Cochrane Risk of Bias tool.

Results: A total of 82 studies met inclusion criteria. Telerehabilitation interventions demonstrated significant long-term improvements in gait speed (mean increase 0.12 m/s, 95% CI: 0.05 to 0.19) and functional mobility (Timed Up and Go Test mean improvement -1.8 seconds, p<0.01). QoL scores improved (PDQ-39 mean difference -5.1 points, 95% CI: -7.8 to -2.4), particularly in domains of emotional well-being and mobility. Adherence rates were high (≥80%), with minimal adverse events. Hybrid models combining telerehabilitation with in-person sessions showed superior outcomes compared to fully remote interventions.

Conclusion: Telerehabilitation is an effective long-term strategy for enhancing mobility and QoL in PD patients. Its integration into routine care may bridge accessibility gaps, though future research should optimize intervention strategies and explore individualized approaches for sustained benefits.

To cite this abstract in AMA style:

A. Elsayed, D. W. Ismail, H. Elshazly, Y. M.HUSSEINY, S. Elrobeigi, Y. Hamdi, M. M. Elsayed. Long-Term Effects of Telerehabilitation on Functional Mobility and Quality of Life in Parkinson’s Disease: A Systematic Review [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/long-term-effects-of-telerehabilitation-on-functional-mobility-and-quality-of-life-in-parkinsons-disease-a-systematic-review/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/long-term-effects-of-telerehabilitation-on-functional-mobility-and-quality-of-life-in-parkinsons-disease-a-systematic-review/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley